Evidence map›Paper›PMID 35077237›Full record

ArticleAngiology2022

The Impact of Hyperuricemia on Patients With Low Body Mass Index After Endovascular Treatments: Data From the I-PAD Registry.

Ayumu Nagae, Soichiro Ebisawa, Tatsuya Saigusa, Ken Nishikawa, Koki Fujimori, Hisanori Yui, Shusaku Maruyama, Chie Nakamura, Daisuke Kashiwagi, Hideki Kobayashi and 7 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Ayumu NagaeDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.ORCID 0000-0001-8358-4360
Soichiro EbisawaDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Tatsuya SaigusaDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Ken NishikawaDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Koki FujimoriDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Hisanori YuiDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Shusaku MaruyamaDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Chie NakamuraDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Daisuke KashiwagiDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Hideki KobayashiDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Takahiro SakaiDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Keisuke SendaDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Tamon KatoDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Takashi MiuraDepartment of Cardiology, 13682Nagano Municipal Hospital, Nagano, Japan.
Ayako OkadaDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Hirohiko MotokiDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Koichiro KuwaharaDepartment of Cardiovascular Medicine, 118108Shinshu University, Matsumoto, Japan.
Shinshu University · JPNagano Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the prognostic effects of hyperuricemia and high or low body mass index (BMI) in peripheral artery disease (PAD) after endovascular therapy (EVT). Between July 2015-2016, 357 consecutive patients with PAD who underwent EVT were enrolled. Patients were divided into 2 groups: BMI < 25 kg/m

Indexed as

Endovascular ProceduresHyperuricemiaPeripheral Arterial DiseaseBody Mass IndexHumansRegistriesRisk FactorsTreatment OutcomeWeight Lossbody mass indexendovascular therapyhyperuricemiaobesityperipheral artery disease

Identifiers

PMID35077237
PMCPMC9485156
OpenAlexW4210730484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.